We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0A43 market cap is 0. The company's latest EPS is USD -0.4950 and P/E is -22.95.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.11M | 7.41M | 1.78M | 10.26M | 832k |
| Operating Income | -114.2M | -87.53M | -301.77M | -269.47M | -143.17M |
| Net Income | -119.36M | -166.41M | -303.66M | -279.82M | -135.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 143.95M | 539.77M | 495.94M | 348.53M | 170.95M |
| Total Liabilities | 138.55M | 78.63M | 96.27M | 126.17M | 53.6M |
| Total Equity | 5.41M | 461.14M | 399.67M | 222.36M | 117.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -97.85M | -177.98M | -215.71M | -216.22M | -124.37M |
| Investing | -9.05M | -58.8M | -175.34M | 109.59M | 87.36M |
| Financing | 105.4M | 465.28M | 211.5M | 81.84M | 5M |
| Market Cap | 0 |
| Price to Earnings Ratio | -22.95 |
| Price to Sales Ratio | 3.79k |
| Price to Cash Ratio | 216.79 |
| Price to Book Ratio | 26.43 |
| Dividend Yield | - |
| Shares Outstanding | 272.99M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Inovio Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.inovio.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
